We are live on ! Find out more
SCA

Summit Creek Advisors Portfolio holdings

AUM $294M
1-Year Est. Return 19.1%
This Fund
S&P 500
This Quarter Est. Return
+9.17%
1 Year Est. Return
+19.1%
3 Year Est. Return
+68.83%
5 Year Est. Return
+84.12%
10 Year Est. Return
+624.17%
AUM
$476M
AUM Growth
-$108M
Cap. Flow
-$148M
Cap. Flow %
-31.04%
Top 10 Hldgs %
30.34%
Holding
56
New
4
Increased
5
Reduced
42
Closed
5

Top Sells

Rank Stock Value
1
CYNO
Cynosure, Inc. Class A
CYNO
+$13.1M
2
MMS icon
Maximus
MMS
+$7.97M
3
SYNA icon
Synaptics
SYNA
+$7.94M
4
SPSC icon
SPS Commerce
SPSC
+$7.23M
5
CAVM
Cavium, Inc.
CAVM
+$6.58M

Sector Composition

Rank Sector Weight
1 Technology 29.52%
2 Healthcare 25.02%
3 Consumer Discretionary 17.51%
4 Industrials 13.89%
5 Financials 4.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HLTH
51
DELISTED
Nobilis Health Corp.
HLTH
$2.43M 0.51%
1,428,786
-417,060
-23% -$867K
SCOR icon
52
Comscore
SCOR
$93M
-9,903
Closed -$6.25M
SPSC icon
53
SPS Commerce
SPSC
$2.82B
-206,824
Closed -$7.23M
SYNA icon
54
Synaptics
SYNA
$4.24B
-148,215
Closed -$7.94M
DPLO
55
DELISTED
DIPLOMAT PHARMACY, INC.
DPLO
-359,435
Closed -$4.53M
CYNO
56
DELISTED
Cynosure, Inc. Class A
CYNO
-286,445
Closed -$13.1M

Similar funds

Summit Creek Advisors's Q1 2017 Portfolio in Review

As of Q1 2017, Summit Creek Advisors held 56 positions worth $476M, down 18% from $585M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Summit Creek Advisors withdrew a net $148M in Q1 2017, closing 5 positions and reducing 42 holdings. Its most notable exit was Cynosure, Inc. Class A, an estimated $13.1M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Summit Creek Advisors opened a new position in LeMaitre Vascular worth $5.31M.

  • Summit Creek Advisors's largest Q1 2017 buy was LeMaitre Vascular: 215,616 shares worth $5.31M.
  • Summit Creek Advisors added most to Omnicell in Q1 2017, an estimated $6.02M increase.
  • Summit Creek Advisors's biggest Q1 2017 reduction was Maximus, cutting an estimated $7.97M.
  • Summit Creek Advisors fully exited Cynosure, Inc. Class A in Q1 2017, selling an estimated $13.1M.
  • Summit Creek Advisors's ten largest holdings make up 30% of its $476M portfolio in Q1 2017.
  • Summit Creek Advisors opened 4 new positions and closed 5 in Q1 2017.
  • Summit Creek Advisors's portfolio value fell 18% quarter-over-quarter to $476M.

Based on Summit Creek Advisors's 13F filing for Q1 2017, filed 21 Apr 2017.